ADPT
Adaptive Biotechnologies Corp
NASDAQ · Healthcare · Biotechnology · US
$23.95
−0.29%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 1261.66x
- P/S forward
- 11.33x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 26.75x
- Price / sales
- 12.41x
- Price / cash flow
- -181.94x
Enterprise value
- Enterprise value
- $3.9B
- EV / sales
- 12.65x
- EV / EBITDA
- -244.10x
- EV / EBIT
- -104.02x
- Market cap
- $3.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026